220 related articles for article (PubMed ID: 32058261)
1. Felbamate in the treatment of refractory epileptic spasms.
Hussain SA; Asilnejad B; Heesch J; Navarro M; Ji M; Shrey DW; Rajaraman RR; Sankar R
Epilepsy Res; 2020 Mar; 161():106284. PubMed ID: 32058261
[TBL] [Abstract][Full Text] [Related]
2. Felbamate for infantile spasms syndrome resistant to first-line treatments.
Dozières-Puyravel B; Nasser H; Bellavoine V; Ilea A; Delanoe C; Auvin S
Dev Med Child Neurol; 2020 May; 62(5):581-586. PubMed ID: 31850517
[TBL] [Abstract][Full Text] [Related]
3. Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG.
Deckard E; Sathe R; Tabibzadeh D; Terango A; Groves A; Rajaraman RR; Nariai H; Hussain SA
Epilepsia Open; 2024 Jun; 9(3):1034-1041. PubMed ID: 38588009
[TBL] [Abstract][Full Text] [Related]
4. Limited efficacy of zonisamide in the treatment of refractory infantile spasms.
Hussain SA; Navarro M; Heesch J; Ji M; Asilnejad B; Peters H; Rajaraman RR; Sankar R
Epilepsia Open; 2020 Mar; 5(1):121-126. PubMed ID: 32140650
[TBL] [Abstract][Full Text] [Related]
5. Treatment with High-Dose Prednisolone in Vigabatrin-Refractory Infantile Spasms.
Al-Shehhi W; Chau V; Boyd J; Snead C; Sharma R; Donner E; Go C; Jain P
Can J Neurol Sci; 2022 Jul; 49(4):532-539. PubMed ID: 34212837
[TBL] [Abstract][Full Text] [Related]
6. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
7. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
[TBL] [Abstract][Full Text] [Related]
9. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
[TBL] [Abstract][Full Text] [Related]
10. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
11. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms.
Yuskaitis CJ; Mytinger JR; Baumer FM; Zhang B; Liu S; Samanta D; Hussain SA; Yozawitz EG; Keator CG; Joshi C; Singh RK; Bhatia S; Bhalla S; Shellhaas R; Harini C;
Neurology; 2022 Nov; 99(22):e2494-e2503. PubMed ID: 36038267
[TBL] [Abstract][Full Text] [Related]
12. Infantile spasms: diagnosis and assessment of treatment response by video-EEG.
Gaily E; Liukkonen E; Paetau R; Rekola R; Granström ML
Dev Med Child Neurol; 2001 Oct; 43(10):658-67. PubMed ID: 11665822
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
[TBL] [Abstract][Full Text] [Related]
17. The use of felbamate to treat infantile spasms.
Hurst DL; Rolan TD
J Child Neurol; 1995 Mar; 10(2):134-6. PubMed ID: 7782604
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
Ohtsuka Y
Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
[TBL] [Abstract][Full Text] [Related]
20. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
